ישראל - עברית - Ministry of Health

novartis israel ltd - mitoxantrone as hydrochloride - תרכיז להכנת תמיסה לאינפוזיה - mitoxantrone as hydrochloride 2 mg/ml - mitoxantrone - mitoxantrone - treatment of advanced breast cancer, non-hodgkin's lymphomas, acute non lymphocytic leukemia palliation of non resectable primary hepatocellular carcinoma. mitoxantrone in combination with corticosterolds is indicated for inital chemotherapy in patients with pain due to advanced hormone-refractory prostate cancer. for reduction of neurologic disability and/or frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remmitting multiple sclerosis (patients whose neurologic status is significantly abnormal between relapses), for patients 18-55 years old.

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate